CAR T-Cell Therapy in Multiple Myeloma : Episode 6
Managing CAR-T Therapy: Side Effect Monitoring and Collaborative Patient Care
Panelists discuss how to monitor and manage adverse effects, particularly chimeric antigen receptor (CAR) T cell–specific reactions, in patients receiving this therapy and how to collaborate with the CAR T-cell therapy team during the treatment phase, emphasizing the most critical aspects of patient care at this stage.
Video content above is prompted by the following:
Dr Castaneda: Ask Jammie:
How do you monitor and manage adverse effects, particularly chimeric antigen receptor (CAR) T cell–specific reactions, in patients who receive this therapy?
Dr Castaneda: Ask Jammie:
How do you collaborate with the CAR T-cell therapy team during the treatment phase, and what aspects of patient care are most critical at this stage?
Related Content
